Oneyear cardiovascular event rates in outpatients with atherothrombosis..

Mortality over a period of 10 years in patients with peripheral arterial disease..

A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences..

Prevalence of peripheral arterial disease —results of the Heinz Nixdorf recall study..

Update on some epidemiologic features of intermittent claudication: the Framingham Study..

Inter- Society Consensus for the Management of Peripheral Arterial Disease (TASC II)..

A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol—the Reykjavik Study..

Temporal trends in the incidence of intermittent claudication from 1950 to 1999..

Cardiovascular determinants of carotid artery disease. The Rotterdam Elderly Study..

Prevalence of and risk factors associated with carotid artery stenosis: the Tromso Study..

Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study..

Prevalence of renovascular disease in the elderly: a population-based study..

The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review..

Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses..

Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases..

Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study..

Peripheral arterial disease —epidemiological aspects..

The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease..

Peripheral arterial disease in the elderly: the Rotterdam Study..

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease..

Epidemiology and natural history of atherosclerotic renovascular disease..

Angiographic prevalence and clinical predictors of left subclavian stenosis in patients undergoing diagnostic cardiac catheterization..

Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis..

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)..

ESC/EAS Guidelines for the managemeint of dyslipidaemias..

Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial..

The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis)..

Rapid magnetic resonance angiography for detection of atherosclerosis..

Wholebody three-dimensional MR angiography with a rolling table platform: initial clinical experience..

Prevention without radiation— a strategy for comprehensive early detection using magnetic resonance tomography]..

Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology—initial clinical results..

Prevalence of peripheral arterial disease: persistence of excess risk in former smokers..

Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication..

Triple-combination pharmacotherapy for medically ill smokers: a randomized trial..

The cardiologist and smoking cessation..

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial..

Aspirin in the primary and secondary prevention of vascular disease: collaborative metaanalysis of individual participant data from randomised trials..

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996; 348:1329-39..

CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events..

Patients with peripheral arterial disease in the CHARISMA trial..

The task force for the management of arterial hypertension of the European Society of Hypertension.The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)..

European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document..

Effects of an angiotensinconverting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators..

Telmisartan, ramipril, or both in patients at high risk for vascular events..

Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials..

Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease..

Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and European Society of Anaesthesiology (ESA)..

Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach..

Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank..

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators..

European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998; 351:1379-87..

The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators..

Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995; 273:1421-8..

Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial..

Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis..

Transatlantic debate. Asymptomatic carotid artery stenosis—medical therapy alone versus medical therapy plus carotid endarterectomy or stenting..

A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack..

Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis—Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003; 229:340-6..

Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess. 2006; 10:iii-iv, ix-x, 1-182..

High-dose atorvastatin after stroke or transient ischemic attack..

Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial..

Patch angioplasty versus primary closure for carotid endarterectomy..

Carotid endarterectomy with a polyurethane patch versus primary closure: a prospective randomized study..

Eversion versus conventional carotid endarterectomy for preventing stroke..

General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial..

10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial..

The benefits of combined anti-platelet treatment in carotid artery stenting..

Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting..

Carotid artery stenting versus surgery: adequate comparisons?..

A randomized trial of carotid artery stenting with and without cerebral protection..

Filter-protected versus unprotected carotid artery stenting: a randomised trial..

Incidence of new brain lesions after carotid stenting with and without cerebral protection..

Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: a systematic review of the current literature..

Embolic protection devices for carotid artery stenting: better results than stenting without protection?..

Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients..

Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE Trial..

New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS)..

Stenting and angioplasty with protection in patients at high-risk for endarterectomy: SAPPHIRE Worldwide Registry first 2,001 patients..

Stenting versus endarterectomy for treatment of carotid-artery stenosis..

Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients..

Hobson RW 2nd, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med. 1993;328:221-7..

Carotid artery stenting vs. endarterectomy..

The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting..

Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS study..

Pro- CAS: a prospective registry of carotid angioplasty and stenting..

Riskadjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry..

Thirty-day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, high-surgical-risk registries..

Early use of Existing Preventive Strategies for Stroke (EXPRESS) study. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison..

Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison..

The importance of initiating ‘best medical therapy’ and intervening as soon as possible in patients with symptomatic carotid artery disease: time for a radical rethink of practice..

Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group..

Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis..

Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery..

Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001; 357:1729-37..

Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis..

Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial..

Differences in complication rates among the centres in the SPACE study..

Protected carotid-artery stenting versus endarterectomy in high-risk patients..

Long-term results of carotid stenting versus endarterectomy in high-risk patients..

Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial..

30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial..

Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial..

Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial..

Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial..

Carotid artery stenting versus carotid endarterectomy: a comprehensive metaanalysis of short-term and long-term outcomes..

Incidence and prognosis of ≥50% symptomatic vertebral or basilar artery stenosis: prospective population-based study..

The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke..

Borderzone infarctions distal to internal carotid artery occlusion: prognostic implications..

Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry..

New England Medical Center Posterior Circulation registry..

Imaging of vertebral artery stenosis: a systematic review..

Surgical reconstruction of the extracranial vertebral artery: management and outcome..

The vital prognosis of subclavian stenosis..

Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction..

Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: long-term results..

Subclavian carotid transposition and bypass grafting: consecutive cohort study and systematic review..

Bypass for chronic ischemia of the upper extremity: results in 20 patients..

Outcomes of endoluminal therapy for ostial disease of the major branches of the aortic arch..

A 7-year experience with thoracoscopic sympathectomy for critical upper limb ischemia..

The clinical course of asymptomatic mesenteric arterial stenosis..

Chronic splanchnic ischaemia..

Celiac territory ischemic syndrome in visceral artery occlusion..

Ischemic gastroparesis: resolution after revascularization..

Intestinal ischemia..

Risk factors for intestinal ischaemia in cardiac surgical patients..

Clinical course of mesenteric artery stenosis in elderly Americans..

Clinical significance of splanchnic artery stenosis..

Chronic mesenteric ischemia. Clinical presentation and diagnosis..

Doppler sonographic criteria for the diagnosis of inferior mesenteric artery stenosis..

Mesenteric duplex scanning: a blinded prospective study..

Visceral duplex scanning: evaluation before and after artery intervention for chronic mesenteric ischemia..

Sonographic assessment of splanchnic arteries and the bowel wall..

Can duplex ultrasound replace arteriography in screening for mesenteric ischemia?..

Noninvasive evaluation of the celiac trunk and superior mesenteric artery with multislice CT in patients with chronic mesenteric ischaemia..

angiography in the diagnosis of mesenteric ischemia..

Evaluating mesenteric ischemia with multidetector-row CT angiography..

Multislice spiral computed tomography angiography of mesenteric arteries..

Jejunal tonometry for the diagnosis of gastrointestinal ischemia. Feasibility, normal values and comparison of jejunal with gastric tonometry exercise testing..

Mesenteric arterial ischaemia: diagnosis and therapeutic options..

Chronic mesenteric ischemia: imaging and percutaneous treatment..

MR angiography: noninvasive vascular imaging of the abdomen..

Mesenteric revascularization: management and outcomes in the United States, 1988-2006..

Surgical versus endovascular reconstruction for chronic mesenteric ischemia: a contemporary UK series..

Long-term outcomes of endoluminal therapy for chronic atherosclerotic occlusive mesenteric disease..

Endovascular versus open revascularization for chronic mesenteric ischemia: a comparative study..

Angioplasty/stenting of the superior mesenteric artery and celiac trunk: early and late outcomes..

Endovascular therapy of chronic mesenteric ischaemia..

Stent placement with the monorail technique for treatment of mesenteric artery stenosis..

Outcomes after endarterectomy for chronic mesenteric ischemia..

Surgical and interventional visceral revascularization for the treatment of chronic mesenteric ischemia—when to prefer which?..

Arteriographic detection of renovascular disease in potential renal donors: incidence and effect on donor surgery..

Assessment of renal artery stenosis severity by pressure gradient measurements..

Atherosclerotic renovascular disease and progressive renal failure..

Risk of atrophy in kidneys with atherosclerotic renal artery stenosis..

Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis..

Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States..

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization..

Chronic kidney disease predicts cardiovascular disease..

Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study..

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study..

Left ventricular morphology and function in patients with atherosclerotic renovascular disease..

The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy?..

The natural history of atherosclerotic and fibrous renal artery disease..

A prospective study of disease progression in patients with atherosclerotic renal artery stenosis..

Jaarsveld van BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342:1007-14..

Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease..

Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization. Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease..

Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements..

AIUM practice guideline for the performance of renal artery duplex sonography. J Ultrasound Med. 2009; 28:120-14..

Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization..

[Color duplex ultrasound imaging of renal arteries and detection of hemodynamically relevant renal artery stenoses]..

Techniques for predicting a favourable response to renal angioplasty in patients with renovascular disease..

Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, Maki JH, Leiner T, et al. Renal Artery Diagnostic Imaging Study in Hypertension (RADISH) Study Group. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141:674-82..

Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy..

Physiological assessment of renal artery stenosis: comparisons of resting with hyperemic renal pressure measurements..

Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension..

The place of renal scintigraphy in the diagnosis of renal artery stenosis.Fifteen years of clinical experience..

Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience..

Survival after stenting of severe atherosclerotic ostial renal artery stenoses..

Angiotensin inhibition in renovascular disease: a population-based cohort study..

Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management..

Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Grou*p. J Hum Hypertens. 1998;12:329-35..

Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction..

Effectiveness of management strategies for renal artery stenosis: a systematic review..

Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure..

Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis..

Renal revascularization for heart failure in patients with atherosclerotic renovascular disease..

Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823-9..

Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis?. A metaanalysis of randomized controlled trials..

Revascularization versus medical therapy for renal-artery stenosis..

Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009; 150:840-8, W150-W841..

The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease..

Atheroembolic renal disease: effect on morbidity and survival after revascularization for atherosclerotic renal artery stenosis..

Cholesterol crystal embolism: a recognizable cause of renal disease..

Embolic protection and platelet inhibition during renal artery stenting..

Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement..

Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology..

Regression of left ventricular hypertrophy following stenting of renal artery stenosis..

RADAR—a randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis..

Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia..

Fibromuscular dysplasia..

The longterm outcomes of percutaneous therapy for renal artery fibromuscular dysplasia..

Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis..

Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial..

Improved renal function and blood pressure control following renal artery angioplasty: the renal artery angioplasty in patients with renal insufficiency and hypertension using a dedicated renal stent device study (PRECISION)..

Primary renal artery stenting: characteristics and outcomes after 363 procedures..

Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years..

Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smaller..

Treatment of instent restenosis following stent-supported renal artery angioplasty..

Optimal treatment of renal artery in-stent restenosis: repeat stent placement versus angioplasty alone..

Percutaneous revascularization of persistent renal artery in-stent restenosis..

Outcomes of endoluminal reintervention for restenosis after percutaneous renal angioplasty and stenting..

Trends in surgical revascularization for renal artery disease. Ten years’ experience..

Safety and efficacy of transaortic renal endarterectomy as an adjunct to aortic surgery..

The durability of different reconstructive techniques for atherosclerotic renal artery disease..

Renal artery surgery in the era of endovascular intervention..

Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD)..

Medical therapy of renovascular hypertension: efficacy and safety of captopril in 269 patients..

Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty..

Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions..

Predictors of improved renal function after percutaneous stentsupported angioplasty of severe atherosclerotic ostial renal artery stenosis..

Delay of dialysis in end-stage renal failure: prospective study on percutaneous renal artery interventions..

The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys..

Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment..

ROC analysis of noninvasive tests for peripheral arterial disease..

The diagnostic value of the measurement of the ankle-brachial systolic pressure index in primary health care..

Variability of Doppler ankle pressures with arterial occlusive disease: an evaluation of ankle index and brachial-ankle pressure gradient..

A modified calculation of ankle-brachial pressure index is far more sensitive in the detection of peripheral arterial disease..

Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease..

The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects..

Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials..

Critical evaluation of stress testing in the diagnosis of peripheral vascular disease..

Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000; 31:S1-296..

Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: status in 1997..

Diagnosis of arterial disease of the lower extremities with duplex ultrasonography..

Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US—a meta-analysis..

Collins R, Cranny G, Burch J, Aguiar-Ibanez R, Craig D, Wright K, et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess. 2007; 11:iii-iv, xi-xiii, 1-184..

Interobserver variation in duplex sonographic scanning in the femoropopliteal tract..

Interobserver variation of colour duplex scanning of the popliteal, tibial and pedal arteries..

Duplex ultrasound surveillance can be worthwhile after arterial intervention..

Is early postoperative duplex scan surveillance of leg bypass grafts clinically important?..

Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial..

Preprocedural imaging: new options to reduce need for contrast angiography..

Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis..

Iliac artery stenosis measurements: comparison of two-dimensional time-of-flight and three-dimensional dynamic gadolinium-enhanced MR angiography..

Peripheral vascular tree stenoses: detection with subtracted and nonsubtracted MR angiography..

Aortic and lower-extremity arterial disease: evaluation with MR angiography versus conventional angiography..

Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography..

Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a metaanalysis..

Noninvasive diagnostic assessment of peripheral vascular disease..

Critical evaluation of venous occlusion plethysmography in the diagnosis of occlusive arterial diseases in the lower limbs..

Exercise for intermittent claudication..

Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis..

Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication..

Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response..

Randomized controlled trial of supervised exercise to evaluate changes in cardiac function in patients with peripheral atherosclerotic disease..

Study on the non-drug, conservative treatment of intermittent claudication..

Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication..

A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication..

Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies..

The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease..

Naftidrofuryl in intermittent claudication: a retrospective analysis..

Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data..

Findings of the Naftidrofuryl in Quality of Life (NIQOL) European study program..

European multicenter study on propionyl-Lcarnitine in intermittent claudication..

Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication..

Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebocontrolled, 4-year study..

Buflomedil for intermittent claudication..

Bias in benefit-risk appraisal in older products: the case of buflomedil for intermittent claudication..

Management of hypertension in peripheral arterial disease..

Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease?. A systematic review and meta-analysis of randomised controlled trials..

Lack of influence of propranolol and metoprolol on walking distance in patients with chronic intermittent claudication..

Beta blockers for peripheral arterial disease..

Ginkgo biloba for intermittent claudication..

Intermittent pneumatic compression for the treatment of lower extremity arterial disease: a systematic review..

A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication..

A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries..

Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training—randomized controlled trial..

Long-term cardiovascular morbidity, mortality, and reintervention after endovascular treatment in patients with iliac artery disease: The Dutch Iliac Stent Trial Study..

Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease..

The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction..

In vitro comparison of self-expanding versus balloon-expandable stents in a human ex vivo model..

Tetteroo E, Van der Graaf Y, Bosch JL, Van Engelen AD, Hunink MG, Eikelboom BC, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet. 1998; 351: 1153-9..

Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting..

Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions..

Prevalence and clinical impact of stent fractures after femoropopliteal stenting..

Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial..

Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg..

Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral- popliteal bypass in the treatment of superficial femoral arterial occlusive disease..

Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelvemonth results from the RESILIENT randomized trial..

Longterm outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia..

Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease..

Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome..

Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease..

Graft type for femoro-popliteal bypass surgery..

Randomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal polytetrafluoroethylene bypass grafting..

PTFE bypass to below-knee arteries: distal vein collar or not?. A prospective randomised multicentre study..

A contemporary metaanalysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting..

A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal aboveknee revascularization: a prospective randomized Department of Veterans Affairs cooperative study..

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplastyfirst revascularization strategy..

Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial..

BASIL TrialParticipants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making..

TASC II section E3 on the treatment of acute limb ischemia: commentary from European interventionists..

Surveillance after lower extremity arterial bypass..

Is duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST)..

The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure..

Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery..

Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet. 2000; 355:346-51..

Department of Veterans Affairs Cooperative Study #362. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study..

Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure..

Belch JJ, Dormandy J; CASPAR Writing Committee. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg. 2010; 52:825-33, 833.e821-2..

Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins..

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial..

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial..

Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia..

Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia..

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication..

Results from a phase II multicenter, double-blind placebocontrolled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease..

Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrowmononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans..

Stem cell therapy in PAD..

Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L, et al; on behalf of the TAMARIS Committees and Investigators. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomized placebocontrolled trial of gene therapy in critical limb ischaemia. Lancet. 2011; 377:1929-37..

Is intermittent claudication improved by percutaneous transluminal angioplasty?. A randomized controlled trial..

The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease..

The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods..

Association of low ankle brachial index with high mortality in primary care..

Critical limb ischemia: medical and surgical management..

Recommended standards for reports dealing with lower extremity ischemia: revised version..

Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007; 45:645-54..

Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial..

Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome..

When should open surgery be the initial option for critical limb ischaemia?..

Crural artery bypass with the autogenous greater saphenous vein..

A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases..

Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia..

Critical and subcritical ischaemia..

Critical analysis of clinical success after surgical bypass for lowerextremity ischemic tissue loss using a standardized definition combining multiple parameters: a new paradigm of outcomes assessment..

Prostanoid drug therapy for peripheral arterial occlusive disease— the European experience..

Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV..

Prostanoids for critical limb ischaemia..

Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia..

Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)..

A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia..

Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg. 1994; 220:251-66..

A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs..

Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)..

Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: the Framingham Study..

Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry..

Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting..

Indications for carotid screening in patients with coronary artery disease..

The preoperative cerebrovascular consultation: common cerebrovascular questions before general or cardiac surgery..

A predictive model for screening cerebrovascular disease in patient undergoing coronary artery bypass grafting..

Multistate population-based outcomes of combined carotid endarterectomy and coronary artery bypass..

Perioperative stroke..

A systematic review of outcome following synchronous carotid endarterectomy and coronary artery bypass: influence of surgical and patient variables..

Concurrent coronary and carotid artery surgery: factors influencing perioperative outcome and long-term results..

Simultaneous carotid endarterectomy and coronary artery bypass surgery in Canada..

Mortality from combined carotid endarterectomy and coronary artery bypass surgery in the US..

Combined carotid endarterectomy and coronary artery bypass grafting in patients with asymptomatic high-grade stenoses: an analysis of 758 procedures..

Combined coronary artery bypass and carotid endarterectomy: long-term results..

Increased risk associated with combined carotid endarterectomy and coronary artery bypass graft surgery: a propensity-matched comparison with isolated coronary artery bypass graft surgery..

The influence of concurrent carotid endarterectomy on coronary bypass: a case-controlled study..

Trends and outcomes of concurrent carotid revascularization and coronary bypass..

Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure)..

Staged carotid artery stenting and coronary artery bypass graft surgery: initial results from a single center..

Is there any benefit from staged carotid and coronary revascularization using carotid stents?. A single-center experience highlights the need for a randomized controlled trial..

Synchronous carotid stenting and cardiac surgery: an initial single-center experience..

Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term results..

The influence of asymptomatic significant carotid disease on mortality and morbidity in patients undergoing coronary artery bypass surgery..

A systematic review and meta-analysis of 30-day outcomes following staged carotid artery stenting and coronary bypass..

Will carotid angioplasty become the preferred alternative to staged or synchronous carotid endarterectomy in patients undergoing cardiac surgery?..

A systematic review of outcomes in patients with staged carotid artery stenting and coronary artery bypass graft surgery..

Stent-protected angioplasty versus carotid endarterectomy in patients with carotid artery stenosis: metaanalysis of randomized trial data..

Simultaneous hybrid revascularization by carotid stenting and coronary artery bypass grafting: the SHARP study..

The prevalence and clinical predictors of atherosclerotic renal artery stenosis in patients undergoing coronary angiography..

Prevalence and risk factors of atherosclerotic renal artery stenosis in 1,200 Chinese patients undergoing coronary angiography..

Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization..

Relation between arteriosclerosis in the coronary and renal arteries..

Renal artery stenosis in patients with coronary artery disease..

Prevalence of renal artery stenosis in 1,656 patients who have undergone cardiac catheterization..

Prevalence of unknown peripheral arterial disease in patients with coronary artery disease: data in primary care from the IPSILON study..

Peripheral arterial disease detection, awareness, and treatment in primary care..

Polyvascular Atherothrombosis Observational Survey Investigators. Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events..

The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients..

Swiss Atherothrombosis Survey: a field report on the occurrence of symptomatic and asymptomatic peripheral arterial disease..

Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators..

Behar S, Zion M, Reicher-Reiss H, Kaplinsky E, Goldbourt U. Short- and longterm prognosis of patients with a first acute myocardial infarction with concomitant peripheral vascular disease. SPRINT Study Group. Am J Med. 1994; 96:15-9..

Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy..

Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy..

Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events)..

Chronic obliterative arterial disease of the lower limbs in the coronary patient: prevalence and prognostic incidence The Monica Toulouse register..

The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials..

Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation..

Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting..

Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study..

Coronaryartery revascularization before elective major vascular surgery..

Poldermans D, Schouten O, Vidakovic R, Bax JJ, Thomson IR, Hoeks SE, et al; DECREASE Study Group. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol. 2007; 49:1763-9..

Coronary angiography in 506 patients with extracranial cerebrovascular disease..

Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease..

Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: a randomised controlled trial..

Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management..

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis..

Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women >or=62 years of age..

Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice..

Excess 1-year cardiovascular risk in elderly primary care patients with a low anklebrachial index (ABI) and high homocysteine level..

Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis..

Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356:1503-16..